famotidine has been researched along with Ventricular Dysfunction, Left in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Ventricular Dysfunction, Left: A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, J | 1 |
| Ogai, A | 1 |
| Nakatani, S | 1 |
| Hashimura, K | 1 |
| Kanzaki, H | 1 |
| Komamura, K | 1 |
| Asakura, M | 1 |
| Asanuma, H | 1 |
| Kitamura, S | 1 |
| Tomoike, H | 1 |
| Kitakaze, M | 1 |
1 trial available for famotidine and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Impact of blockade of histamine H2 receptors on chronic heart failure revealed by retrospective and prospective randomized studies.
Topics: Aged; Cardiac Output, Low; Chronic Disease; Famotidine; Female; Gastroesophageal Reflux; Histamine H | 2006 |